VASO Corp has filed definitive additional materials ahead of its annual meeting scheduled for December 8, 2026. This filing is significant for shareholders as it outlines key proposals, including the election of directors.

The company is preparing for an important governance decision, which could shape its future direction. Shareholders are encouraged to participate in the voting process, which will take place both online and in person at the meeting venue.

Background

VASO Corp, classified under the SIC code 3845, operates in the electromedical and electrotherapeutic apparatus industry. The company is traded on the OTC exchange under the ticker symbol VASO. Recently, VASO Corp has filed several documents with the SEC, including a definitive proxy statement and quarterly reports.

What the Filing Says

The filing, accession number 0001213900-26-113713, provides details about the upcoming annual meeting. It includes information on the election of directors, with nominees Jun Ma and Shaun McMeans proposed to serve until the annual meeting of stockholders in 2029. The filing emphasizes the importance of shareholder participation in the voting process.

Impact

This filing may affect shareholders who are keen on the governance and strategic direction of VASO Corp. The decisions made during this meeting could influence the company's operations and market positioning within the electromedical sector.

What's Next

Shareholders are encouraged to review the materials and participate in the voting process by December 7, 2026, at 11:59 PM ET. The meeting will be held the following day, and shareholders can vote in person or online.